Fever in under 5s: assessment and initial management

Supporting evidence

• Surveillance report

• April 2025 exceptional surveillance of fever in under 5s: assessment and initial management (NICE guideline NG143)

• 2022 exceptional surveillance on intravenous fluid therapy in children and young people (NICE guidelines NG29, NG51, NG143, CG84, CG102 and NG18)

• Appendix A: NICE guideline recommendations and the evidence underlying them (PDF 334 KB)

  Published:

  21 October 2022

• Evidence review

• Evidence review - November 2019

• A: Signs and symptoms predicting Kawasaki disease (PDF 3.88 MB)

  Published:

  07 November 2019

• Full guidance

• Full guideline – May 2013

• Full guideline (PDF 7.51 MB)

  Published:

  22 May 2013

• Appendices A – L (PDF 6.65 MB)

  Published:

  22 May 2013

• Appendix H Evidence tables (PDF 5.76 MB)

  Published:

  22 May 2013